BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30904591)

  • 1. The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers.
    Tolba MF; Omar HA; Hersi F; Nunes ACF; Noreddin AM
    Mol Cell Endocrinol; 2019 May; 488():79-88. PubMed ID: 30904591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
    Lehmann L; Jiang L; Wagner J
    Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol
    Kim JH; Lee J; Jeong H; Bang MS; Jeong JH; Chang M
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells.
    Salama SA; Kamel MW; Botting S; Salih SM; Borahay MA; Hamed AA; Kilic GS; Saeed M; Williams MY; Diaz-Arrastia CR
    PLoS One; 2009 Oct; 4(10):e7356. PubMed ID: 19809499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
    Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
    Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells.
    Allam RM; Al-Abd AM; Khedr A; Sharaf OA; Nofal SM; Khalifa AE; Mosli HA; Abdel-Naim AB
    Toxicol Lett; 2018 Jul; 291():77-85. PubMed ID: 29654831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential protective effects of estradiol and 2-methoxyestradiol in ischemia reperfusion-induced kidney injury in ovariectomized female rats.
    Hassan E; Allam S; Mansour AM; Shaheen A; Salama SA
    Life Sci; 2022 May; 296():120441. PubMed ID: 35240160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer.
    Janacova L; Stenckova M; Lapcik P; Hrachovinova S; Bouchalova P; Potesil D; Hrstka R; Müller P; Bouchal P
    Sci Rep; 2023 Jan; 13(1):1285. PubMed ID: 36690660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor effect of catechol-O-methyltransferase gene in prostate cancer.
    Hashimoto Y; Shiina M; Maekawa S; Kato T; Shahryari V; Kulkarni P; Dasgupta P; Yamamura S; Saini S; Tabatabai ZL; Dahiya R; Tanaka Y
    PLoS One; 2021; 16(9):e0253877. PubMed ID: 34587154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.
    Gizard F; Robillard R; Barbier O; Quatannens B; Faucompré A; Révillion F; Peyrat JP; Staels B; Hum DW
    Mol Cell Biol; 2005 Jun; 25(11):4335-48. PubMed ID: 15899840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
    Tanaka S; Suzuki K; Sakaguchi M
    Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells.
    Wagner J; Jiang L; Lehmann L
    Adv Exp Med Biol; 2008; 617():625-32. PubMed ID: 18497090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.
    Chang I; Liu J; Majid S; Saini S; Zaman MS; Yamamura S; Shahryari V; Chiyomaru T; Deng G; Dahiya R; Tanaka Y
    Carcinogenesis; 2012 Feb; 33(2):420-6. PubMed ID: 22159223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk.
    Ho PW; Garner CE; Ho JW; Leung KC; Chu AC; Kwok KH; Kung MH; Burka LT; Ramsden DB; Ho SL
    Curr Drug Metab; 2008 May; 9(4):304-9. PubMed ID: 18473748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
    Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
    Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Methoxyestradiol ameliorates metabolic syndrome-induced hypertension and catechol-O-methyltransferase inhibited expression and activity in rats.
    Azhar AS; Zaher ZF; Ashour OM; Abdel-Naim AB
    Eur J Pharmacol; 2020 Sep; 882():173278. PubMed ID: 32544503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.